Publications
- Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines2022 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The WNT/beta-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro2019 | Second Faculty of Medicine
- Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer2018 | Second Faculty of Medicine, First Faculty of Medicine
- Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients2017 | Second Faculty of Medicine
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Immunotherapy of prostate cancer2014 | Second Faculty of Medicine
- Immunotherapy for prostate cancer +32013 | Second Faculty of Medicine
- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- News in immunology2023 | Second Faculty of Medicine
- Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy2022 | Second Faculty of Medicine
Loading network view...